BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

542 related articles for article (PubMed ID: 8108135)

  • 1. junB promoter regulation: Ras mediated transactivation by c-Ets-1 and c-Ets-2.
    Coffer P; de Jonge M; Mettouchi A; Binetruy B; Ghysdael J; Kruijer W
    Oncogene; 1994 Mar; 9(3):911-21. PubMed ID: 8108135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oncogenic Ras can induce transcriptional activation through a variety of promoter elements, including tandem c-Ets-2 binding sites.
    Galang CK; Der CJ; Hauser CA
    Oncogene; 1994 Oct; 9(10):2913-21. PubMed ID: 8084596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transactivation of GATA-1 promoter with ETS1, ETS2 and ERGB/Hu-FLI-1 proteins: stabilization of the ETS1 protein binding on GATA-1 promoter sequences by monoclonal antibody.
    Seth A; Robinson L; Thompson DM; Watson DK; Papas TS
    Oncogene; 1993 Jul; 8(7):1783-90. PubMed ID: 8510925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcriptional regulation of the junB promoter: analysis of STAT-mediated signal transduction.
    Coffer P; Lutticken C; van Puijenbroek A; Klop-de Jonge M; Horn F; Kruijer W
    Oncogene; 1995 Mar; 10(5):985-94. PubMed ID: 7898939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The activity of the Ets transcription factor PEA3 is regulated by two distinct MAPK cascades.
    O'Hagan RC; Tozer RG; Symons M; McCormick F; Hassell JA
    Oncogene; 1996 Sep; 13(6):1323-33. PubMed ID: 8808707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Signal transduction and the Ets family of transcription factors.
    Yordy JS; Muise-Helmericks RC
    Oncogene; 2000 Dec; 19(55):6503-13. PubMed ID: 11175366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The transcription of the intercellular adhesion molecule-1 is regulated by Ets transcription factors.
    de Launoit Y; Audette M; Pelczar H; Plaza S; Baert JL
    Oncogene; 1998 Apr; 16(16):2065-73. PubMed ID: 9572487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of the ras-mitogen-activated protein kinase pathway and phosphorylation of ets-2 at position threonine 72 in human ovarian cancer cell lines.
    Patton SE; Martin ML; Nelsen LL; Fang X; Mills GB; Bast RC; Ostrowski MC
    Cancer Res; 1998 May; 58(10):2253-9. PubMed ID: 9605774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dual control of myc expression through a single DNA binding site targeted by ets family proteins and E2F-1.
    Roussel MF; Davis JN; Cleveland JL; Ghysdael J; Hiebert SW
    Oncogene; 1994 Feb; 9(2):405-15. PubMed ID: 8290253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Menin uncouples Elk-1, JunD and c-Jun phosphorylation from MAP kinase activation.
    Gallo A; Cuozzo C; Esposito I; Maggiolini M; Bonofiglio D; Vivacqua A; Garramone M; Weiss C; Bohmann D; Musti AM
    Oncogene; 2002 Sep; 21(42):6434-45. PubMed ID: 12226747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcriptional regulation of the junB promoter in mature B lymphocytes. Activation through a cyclic adenosine 3',5'-monophosphate-like binding site.
    Amato SF; Nakajima K; Hirano T; Chiles TC
    J Immunol; 1996 Jul; 157(1):146-55. PubMed ID: 8683108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stimulation of the P-450 side chain cleavage enzyme (CYP11A1) promoter through ras- and Ets-2-signaling pathways.
    Pestell RG; Albanese C; Watanabe G; Lee RJ; Lastowiecki P; Zon L; Ostrowski M; Jameson JL
    Mol Endocrinol; 1996 Sep; 10(9):1084-94. PubMed ID: 8885243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Downregulation of c-fos gene transcription in cells transformed by E1A and cHa-ras oncogenes: a role of sustained activation of MAP/ERK kinase cascade and of inactive chromatin structure at c-fos promoter.
    Kukushkin AN; Abramova MV; Svetlikova SB; Darieva ZA; Pospelova TV; Pospelov VA
    Oncogene; 2002 Jan; 21(5):719-30. PubMed ID: 11850800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The PEA3 Ets transcription factor is a downstream target of the HER2/Neu receptor tyrosine kinase.
    O'Hagan RC; Hassell JA
    Oncogene; 1998 Jan; 16(3):301-10. PubMed ID: 9467955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cellular and viral trans-acting factors modulate N-myc2 promoter activity in woodchuck liver tumors.
    Flajolet M; Gegonne A; Ghysdael J; Tiollais P; Buendia MA; Fourel G
    Oncogene; 1997 Aug; 15(9):1103-10. PubMed ID: 9285565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin-like growth factor-1 stimulates rat prolactin gene expression by a Ras, ETS and phosphatidylinositol 3-kinase dependent mechanism.
    Castillo AI; Tolon RM; Aranda A
    Oncogene; 1998 Apr; 16(15):1981-91. PubMed ID: 9591782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ets up-regulates MET transcription.
    Gambarotta G; Boccaccio C; Giordano S; Andŏ M; Stella MC; Comoglio PM
    Oncogene; 1996 Nov; 13(9):1911-7. PubMed ID: 8934537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Smad3/AP-1 interactions control transcriptional responses to TGF-beta in a promoter-specific manner.
    Verrecchia F; Vindevoghel L; Lechleider RJ; Uitto J; Roberts AB; Mauviel A
    Oncogene; 2001 Jun; 20(26):3332-40. PubMed ID: 11423983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ETS1 and ETS2 in p53 regulation: spatial separation of ETS binding sites (EBS) modulate protein: DNA interaction.
    Venanzoni MC; Robinson LR; Hodge DR; Kola I; Seth A
    Oncogene; 1996 Mar; 12(6):1199-1204. PubMed ID: 8649821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of gene expression by transcription factors Ets-1 and Ets-2.
    Tymms MJ; Kola I
    Mol Reprod Dev; 1994 Oct; 39(2):208-14. PubMed ID: 7826624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.